Monthly Archives: February 2014

Endo Pharmaceuticals Settles False Claim Act Case Over Liboderm Patch for $172 Million

Written February 25, 2014 by Robert Lu

On February 21, 2014, the U.S. Attorney’s Office for the Eastern District of Pennsylvania announced that pharmaceuticals company Endo Health Solutions, Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo), which is headquartered in Malvern, Pennsylvania, have agreed to pay $171.9 million to resolve civil allegations of off-label marketing of their adhesive pain patch Lidoderm.
Continue reading

JPMorgan Chase to Pay $614 Million to Settle False Claims Act Case Related to FHA-insured and VA-guaranteed Mortgage Loans

Written February 7, 2014 by Robert Lu

On Tuesday, February 4, 2014, the Department of Justice announced that JPMorgan Chase (JPMC) will pay $614 million for violating the False Claims Act by knowingly originating and underwriting non-compliant mortgage loans submitted for insurance coverage and guarantees by the Department of Housing and Urban Development’s (HUD) Federal Housing Administration (FHA) and the Department of Veterans Affairs (VA).
Continue reading

Saint Joseph Health System Inc. Agrees To Pay Government $16.5 Million To Settle False Claims Act Lawsuit

Written February 1, 2014 by Robert Lu

On January 29, 2014, the U.S.

Department of Justice announced that Saint Joseph Health System Inc. has agreed to pay the government  $16.5 million to resolve civil allegations that it submitted false or fraudulent claims to the Medicare and Kentucky Medicaid programs for a variety of medically unnecessary heart procedures.
Continue reading